Replies to post #568138 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Hidden within your shadowy post are imminent positive prescribed events.

[biosectinvestor]

You ironically say two contradictory things at once.

1) The street and BP partners see "serious issues with this management team", implying no deal is likely, very bad, bad, bad.
2) There's a plan to sweep the exiting team aside and put in a new C suite and board, and that is why they have not had a CFO. Now it's planned. Planned with whom? Sounds like it is planned with a BP.
3) Then back again to the no CFO is bottom feeder style management.

The post is filled with contradictions. I can see how getting the price down before a buyout would be helpful to the bottom lines of some, but it's just right out there. No subtlety.

[Maverick0408]

Agreed. Ultimately, this misery will end but when is the real question. This management and board is not getting any younger (some in their 70s and 80s). Shorts are not going to give up until FDA approvals and this management has shown no real intent and strategic planning on supporting investors around some of the most important catalysts.

Hiring that new scientist/investor relations guy in Dec 2022 makes me think there is nothing concrete at this time and he was brought in to attract new investors?